SUBJECT_ID	PARENT_ID	TYPE	TIMEPOINT	METHOTREXATE_SENSITIVITY	ATCC_LINK	ALTERNATE_NAME	SOURCE	GROWTH_PROPERTIES	ORGANISM	MORPHOLOGY	AGE	GENDER	RACE	PROPERTIES_CELLULAR_PRODUCTS	BLOOD_TYPE	RH_TYPE	HLA_PROFILE	ISOLATION_DATE	TUMORIGENIC	ER_STATUS	PGR_STATUS	MYC_STATUS	RAS_STATUS	MTB_STATUS	FOS_STATUS	SIS_STATUS	P53_IHC_STATUS	ABL_STATUS	ROS_STATUS	SRC_STATUS	CYTOGENETIC_ANALYSIS	MICROARRAY_DETAILS	CELL_CULTURE_DETAILS	DRUG_OR_AGENT_DETAILS
HT29		CELL_LINE			http://www.atcc.org/ATCCAdvancedCatalogSearch/ProductDetails/tabid/452/Default.aspx?ATCCNum=HTB-38&Template=cellBiology	HTB-38	COLON CANCER	ADHERENT	HUMAN	EPITHELIAL	44	FEMALE	CAUCASIAN	PRODUCING CARCINOEMBRYONIC ANTIGEN||RELEASING SECRETORY COMPONENT OF IGA	A	RH+	A1||A3||B12||B17||CW5	1964	YES			POSITIVE	POSITIVE	POSITIVE	POSITIVE	POSITIVE	POSITIVE	NEGATIVE	NEGATIVE	NEGATIVE	MODAL NUMBER = 71||RANGE = 68 TO 72.	Method of RNA isolation:  RNeasy Mini Kit from Qiagen|| Method of labeling: Biotin||GeneChip Method of hybridization:Human Genome U133 PLUS 2.0 from Affymetrix	Media and Supplements: Human colon adenocarcinoma cell line HT29 was routinely grown in Ham's F12 medium supplemented with 7% fetal bovine serum (FBS) at 37°C in a 5% CO2 humidified atmosphere.	
HT29_SENSITIVE_1	HT29	REPLICATE		SENSITIVE																														
HT29_SENSITIVE_2	HT29	REPLICATE		SENSITIVE																														
HT29_SENSITIVE_3	HT29	REPLICATE		SENSITIVE																														
HT29_RESISTANT_1	HT29	REPLICATE		RESISTANT																														
HT29_RESISTANT_2	HT29	REPLICATE		RESISTANT																														
HT29_RESISTANT_3	HT29	REPLICATE		RESISTANT																														